BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24072051)

  • 21. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.
    Schmucker S; Puccio H
    Hum Mol Genet; 2010 Apr; 19(R1):R103-10. PubMed ID: 20413654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Friedreich's ataxia-vitamin E responsive type. The chromosome 8 locus.
    Belal S; Hentati F; Ben Hamida C; Ben Hamida M
    Clin Neurosci; 1995; 3(1):39-42. PubMed ID: 7614093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cerebellar bioenergetic state predicts treatment response in COQ8A-related ataxia.
    Prasuhn J; Göttlich M; Ebeling B; Bodemann C; Großer S; Wellach I; Reuther K; Hanssen H; Brüggemann N
    Parkinsonism Relat Disord; 2022 Jun; 99():91-95. PubMed ID: 35642996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome.
    Harding AE; Muller DP; Thomas PK; Willison HJ
    Ann Neurol; 1982 Nov; 12(5):419-24. PubMed ID: 7181449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinocerebellar ataxias due to mitochondrial defects.
    Kaplan J
    Neurochem Int; 2002 May; 40(6):553-7. PubMed ID: 11850112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.
    Hadjivassiliou M
    CNS Neurol Disord Drug Targets; 2019; 18(6):423-431. PubMed ID: 29268693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebellar ataxias.
    Manto M; Marmolino D
    Curr Opin Neurol; 2009 Aug; 22(4):419-29. PubMed ID: 19421057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal-recessive cerebellar ataxias.
    Fogel BL
    Handb Clin Neurol; 2018; 147():187-209. PubMed ID: 29325611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitrogen-bisphosphonate therapy is linked to compromised coenzyme Q10 and vitamin E status in postmenopausal women.
    Kalyan S; Huebbe P; Esatbeyoglu T; Niklowitz P; Côté HC; Rimbach G; Kabelitz D
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1307-13. PubMed ID: 24423355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coenzyme Q10 and immunity: A case report and new implications for treatment of recurrent infections in metabolic diseases.
    Farough S; Karaa A; Walker MA; Slate N; Dasu T; Verbsky J; Fusunyan R; Canapari C; Kinane TB; Van Cleave J; Sweetser DA; Sims KB; Walter JE
    Clin Immunol; 2014 Dec; 155(2):209-12. PubMed ID: 25264263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory investigations.
    Boltshauser E; Weber KP
    Handb Clin Neurol; 2018; 154():287-298. PubMed ID: 29903445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of inherited ataxias in the province of Padua, Italy.
    Zortea M; Armani M; Pastorello E; Nunez GF; Lombardi S; Tonello S; Rigoni MT; Zuliani L; Mostacciuolo ML; Gellera C; Di Donato S; Trevisan CP
    Neuroepidemiology; 2004; 23(6):275-80. PubMed ID: 15297793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin-responsive disorders: cobalamin, folate, biotin, vitamins B1 and E.
    Baumgartner MR
    Handb Clin Neurol; 2013; 113():1799-810. PubMed ID: 23622402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary ataxias].
    Tallaksen CM
    Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1977-80. PubMed ID: 18787576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Classification of Autosomal Recessive Cerebellar Ataxias: a Consensus Statement from the Society for Research on the Cerebellum and Ataxias Task Force.
    Beaudin M; Matilla-Dueñas A; Soong BW; Pedroso JL; Barsottini OG; Mitoma H; Tsuji S; Schmahmann JD; Manto M; Rouleau GA; Klein C; Dupre N
    Cerebellum; 2019 Dec; 18(6):1098-1125. PubMed ID: 31267374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
    Hart PE; Lodi R; Rajagopalan B; Bradley JL; Crilley JG; Turner C; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Friedreich's ataxia: coenzyme Q10 and vitamin E therapy.
    Cooper JM; Schapira AH
    Mitochondrion; 2007 Jun; 7 Suppl():S127-35. PubMed ID: 17485244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reply to Drug Insight: antioxidant therapy in inherited ataxias.
    Gohil K; Azzi A
    Nat Clin Pract Neurol; 2008 Jul; 4(7):E1; author reply E2. PubMed ID: 18600251
    [No Abstract]   [Full Text] [Related]  

  • 39. Keys to overcoming the challenge of diagnosing autosomal recessive spinocerebellar ataxia.
    Arias M
    Neurologia (Engl Ed); 2019 May; 34(4):248-258. PubMed ID: 27460185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebellar and afferent ataxias.
    Pandolfo M; Manto M
    Continuum (Minneap Minn); 2013 Oct; 19(5 Movement Disorders):1312-43. PubMed ID: 24092292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.